Pancreatic fat accumulation evaluated by multidetector computed tomography in patients with type2 diabetes.

Abstract

AimsTo clarify the clinical impact of pancreatic fat volume on beta cell function in type 2 diabetes patients.Materials and MethodsOne hundred thirty two consecutive type 2 diabetic patients (mean age, 63.7 years) were enrolled in this cross‐sectional study. Total pancreatic volume (TPV), pancreatic fat volume (PFV), and pancreatic parenchymal volume (PPV), and visceral fat volume were examined quantitatively with multidetector computed tomography using SYNAPSE VINCENT image analysis system (Fujifilm Inc., Tokyo, Japan). Pancreatic fat was identified using Hounsfield Units of less than zero. The capacity of insulin secretion was assessed by C‐peptide immunoreactivity (CPR) index (100 × fasting CPR/fasting plasma glucose). Insulin sensitivity was evaluated using CPR‐insulin resistance (20/fasting CPR × fasting plasma glucose).ResultsTPV, PFV, PPV, and visceral fat volume were significantly correlated with body weight (BW). PPV/BW, but not PFV/BW, significantly decreased with increasing duration of diabetes and aging. PFV/BW was positively associated with body mass index and visceral fat volume/BW. PFV/BW was significantly correlated with CPR index, while inversely associated with insulin sensitivity. CPR index, but not CPRinsulin resistance was progressively decreased in patients with a longer duration of diabetes. When patients were divided into two groups according to a median PFV/BW value, CPR index in high PFV/BW group with diabetes duration >5 years was significantly lower than those ≤5 years. However, duration‐dependent decrease in CPR index was not observed in low PFV/BW group.ConclusionsOur present study suggests that PFV might predict the progression of beta cell dysfunction in patients with type 2 diabetes.